Evidence map›Paper›PMID 25950714›Full record

ArticlePloS one2015

DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.

Ruth Wang'ondu, Stuart Teal, Richard Park, Lee Heston, Henri Delecluse, George Miller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Reconstructing EBV reactivation and DNA damage response kinetics in morphologic pseudotime.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Arginine Metabolism SupportsbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Epstein-Barr virus protein BKRF4 restricts nucleosome assembly to suppress host antiviral responses.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ruth Wang'onduDepartment of Cell Biology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Stuart TealDepartment of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Richard ParkDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Lee HestonDepartment of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Henri DelecluseGerman Cancer Research Centre, Heidelberg, Germany; Inserm Unit, Heidelberg, Germany.
George MillerDepartment of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut, United States of America; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States of America; Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Yale University · USGerman Cancer Research Center · DE

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
VIRAL SMALL RNPS--ROLES IN CELL TRANSFORMATIONP01CA016038 · NCI · YALE UNIVERSITY · PI DIMAIO, DANIEL C. · 1985 to 2020
$25.6M
STUDIES OF EPSTEIN-BARR VIRUSR37CA012055 · NCI · YALE UNIVERSITY · PI MILLER, I. GEORGE · 1989 to 2012
$4.4M
STUDIES OF EPSTEIN-BARR VIRUSR01CA012055 · NCI · YALE UNIVERSITY · PI MILLER, I. GEORGE · 1985 to 2002
$737k
NCI NIH HHS CA12055NCI NIH HHS CA16038NCI NIH HHS P01 CA016038NCI NIH HHS R01 CA012055NCI NIH HHS R37 CA012055NIGMS NIH HHS T32 GM007205NIGMS NIH HHS TG2T32GM07205
6 · The paper itself

Abstract

Epstein Barr virus (EBV), like other oncogenic viruses, modulates the activity of cellular DNA damage responses (DDR) during its life cycle. Our aim was to characterize the role of early lytic proteins and viral lytic DNA replication in activation of DNA damage signaling during the EBV lytic cycle. Our data challenge the prevalent hypothesis that activation of DDR pathways during the EBV lytic cycle occurs solely in response to large amounts of exogenous double stranded DNA products generated during lytic viral DNA replication. In immunofluorescence or immunoblot assays, DDR activation markers, specifically phosphorylated ATM (pATM), H2AX (γH2AX), or 53BP1 (p53BP1), were induced in the presence or absence of viral DNA amplification or replication compartments during the EBV lytic cycle. In assays with an ATM inhibitor and DNA damaging reagents in Burkitt lymphoma cell lines, γH2AX induction was necessary for optimal expression of early EBV genes, but not sufficient for lytic reactivation. Studies in lytically reactivated EBV-positive cells in which early EBV proteins, BGLF4, BGLF5, or BALF2, were not expressed showed that these proteins were not necessary for DDR activation during the EBV lytic cycle. Expression of ZEBRA, a viral protein that is necessary for EBV entry into the lytic phase, induced pATM foci and γH2AX independent of other EBV gene products. ZEBRA mutants deficient in DNA binding, Z(R183E) and Z(S186E), did not induce foci of pATM. ZEBRA co-localized with HP1β, a heterochromatin associated protein involved in DNA damage signaling. We propose a model of DDR activation during the EBV lytic cycle in which ZEBRA induces ATM kinase phosphorylation, in a DNA binding dependent manner, to modulate gene expression. ATM and H2AX phosphorylation induced prior to EBV replication may be critical for creating a microenvironment of viral and cellular gene expression that enables lytic cycle progression.

Indexed as

DNA DamageAtaxia Telangiectasia Mutated ProteinsCell LineChromobox Protein Homolog 5DeoxyribonucleasesDNA ReplicationDNA, ViralEpstein-Barr Virus InfectionsGene Expression Regulation, NeoplasticHerpesvirus 4, HumanHistonesHumansImmediate-Early ProteinsIntracellular Signaling Peptides and ProteinsPhosphorylationProtein Serine-Threonine KinasesAtaxia Telangiectasia Mutated ProteinsBGLF4 protein, Epstein-Barr virusBRLF1 protein, Human herpesvirus 4BZLF1 protein, Herpesvirus 4, HumanCBX1 protein, humanChromobox Protein Homolog 5deoxyribonuclease, Epstein-Barr virusDeoxyribonucleasesDNA, ViralH2AX protein, humanHistonesImmediate-Early ProteinsIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesTP53BP1 protein, humanTrans-ActivatorsTumor Suppressor p53-Binding Protein 1Viral Proteins

Identifiers

PMID25950714
PMCPMC4423948
OpenAlexW279926394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.